Highway Pharmaceuticals Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Highway Pharmaceuticals General Information

Description

Developer of pharmaceutical therapeutics designed to treat autoimmune and chronic diseases in animals and humans. The company develops oral liquid combination drugs with modified immunosuppressant formulations, including cyclosporine and sirolimus-based therapies, using metabolic modulation to improve dosing frequency, absorption, and safety profiles, enabling veterinary and healthcare markets to access treatments for conditions such as feline stomatitis and chronic kidney disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 95 Mount Vernon Street
  • Boston, MA 02108
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 95 Mount Vernon Street
  • Boston, MA 02108
  • United States

Highway Pharmaceuticals Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Highway Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Sep-2023 Completed Clinical Trials - General
2. Equity Crowdfunding 01-Feb-2023 Completed Clinical Trials - General
1. Angel (individual) 01-Sep-2022 $195K $195K Completed Clinical Trials - General
To view Highway Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Highway Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Thoobik Holdings Venture Capital Minority
To view Highway Pharmaceuticals’s complete investors history, request access »

Highway Pharmaceuticals FAQs

  • When was Highway Pharmaceuticals founded?

    Highway Pharmaceuticals was founded in 2021.

  • Where is Highway Pharmaceuticals headquartered?

    Highway Pharmaceuticals is headquartered in Boston, MA.

  • What industry is Highway Pharmaceuticals in?

    Highway Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Highway Pharmaceuticals a private or public company?

    Highway Pharmaceuticals is a Private company.

  • What is Highway Pharmaceuticals’s current revenue?

    The current revenue for Highway Pharmaceuticals is .

  • How much funding has Highway Pharmaceuticals raised over time?

    Highway Pharmaceuticals has raised $302K.

  • Who are Highway Pharmaceuticals’s investors?

    Thoobik Holdings has invested in Highway Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process